STRIDE Program for Diabetes
(STRIDE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the STRIDE Program, designed to help parents recently diagnosed with type 2 diabetes manage their health while caring for their family. The program provides virtual sessions on self-care, healthy eating, and family activities, along with personalized support through text messages. Participants will either receive this new program alongside their usual care or continue with their usual care, with the option to try the program later. This trial suits English-speaking Kaiser Permanente Northern California members who have managed type 2 diabetes for less than five years and are primary caregivers to children aged 2-14. As an unphased trial, it offers a unique opportunity to explore innovative support strategies for managing diabetes while balancing family responsibilities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the STRIDE Program is safe for participants?
Research has shown that the STRIDE Program aids people with type 2 diabetes by emphasizing lifestyle changes rather than medication or medical procedures. This approach eliminates drug-related side effects.
The program includes live and recorded sessions led by a healthcare professional, along with personalized text messages. Participants in similar programs often report increased confidence and improved management of their condition. Because the program avoids medical treatments, it carries very low risk. The goal is to equip participants with skills for better self-care, making it a safe choice for those seeking more effective diabetes management.12345Why are researchers excited about this trial?
Researchers are excited about the STRIDE Program for diabetes because it offers a unique approach by combining live and recorded sessions led by a clinician with personalized text message support. Unlike traditional diabetes care, which often relies on medications and lifestyle advice without ongoing engagement, the STRIDE Program provides continuous, tailored support designed to motivate and guide patients in managing their condition. This innovative method could enhance patient adherence to treatment plans and improve long-term health outcomes, setting it apart from usual care practices.
What evidence suggests that the STRIDE Program is effective for type 2 diabetes?
Research shows that lifestyle programs like the STRIDE Program, which participants in this trial may receive, can help manage type 2 diabetes. Past studies have demonstrated that similar programs aid in weight loss and better blood sugar control. For instance, some participants were more than twice as likely to achieve normal blood sugar levels after a year. These programs teach practical skills such as self-care, healthy eating, and engaging in family activities, which can enhance health for those with diabetes. Although specific data for the STRIDE Program is not yet available, these findings suggest that similar methods can effectively manage type 2 diabetes.12678
Who Is on the Research Team?
Anjali Gopalan, MD, MS
Principal Investigator
Kaiser Permanente
Are You a Good Fit for This Trial?
This trial is for adults aged 21-44 who have been diagnosed with type 2 diabetes in the past 5 years, are primary caregivers to at least one child aged 2-14, are Kaiser Permanente Northern California members, speak English, can get text messages, and can join virtual sessions.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the STRIDE program, including live and recorded sessions led by a clinician and 24 tailored text messages, in addition to their usual diabetes care
Follow-up
Participants are monitored for diabetes distress, self-efficacy, HbA1c levels, and self-reported diabetes self-management
What Are the Treatments Tested in This Trial?
Interventions
- STRIDE Program
Trial Overview
The study tests STRIDE—a virtual program that teaches parents practical skills for managing diabetes. Sessions focus on self-care, healthy eating as a family, and being active together. The goal is to help parents manage their diabetes while caring for young children.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants enrolled in the STRIDE arm will be invited to attend the live and recorded sessions let by a clinician and receive 24 tailored text messages, in addition to their usual diabetes care.
This arm will continue to receive their usual diabetes care. After completing 6-month outcome assessments, they will be offered an opportunity to participate in the STRIDE program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kaiser Permanente
Lead Sponsor
Citations
NCT07544407 | STRIDE: Supporting Early Diabetes Self- ...
This study will test STRIDE (SupporTing paRents with DiabEtes), a virtually delivered program that helps adults ages 21-44 who were recently ...
Semaglutide and walking capacity in people with ...
Semaglutide increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.
STRIDE and SOUL: Semaglutide Improves PAD Outcomes
Results showed that patients taking semaglutide had a median improvement of 26 meters and an average improvement of 40 meters, representing a ...
Semaglutide and walking capacity in people with ...
STRIDE was a double-blind, randomised, placebo-controlled trial done at 112 outpatient clinical trial sites in 20 countries in North America, ...
STRIDE Program for Diabetes · Info for Participants
This study will test STRIDE (SupporTing paRents with DiabEtes), a virtually delivered program that helps adults ages 21-44 who were recently ...
Baseline patient reported outcomes in patients with peripheral ...
Participants in STRIDE, characterized as having early-stage symptomatic PAD, have reported moderate-to-high impact on their physical functioning ...
Semaglutide and Walking Capacity in People With ...
The results of the STRIDE trial showed that semaglutide was associated with a higher estimated ratio of MWD in patients with symptomatic PAD ...
8.
vascularnews.com
vascularnews.com/stride-trial-analysis-confirms-potential-impact-of-semaglutide-on-quality-of-life-metrics-for-pad-patients-with-diabetes/STRIDE trial analysis confirms potential impact of ...
Semaglutide was well tolerated, with no treatment-related deaths and a low rate of serious adverse events (1%), consistent with its known safety ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.